cons of glp 1 drugs Why GLP-1 Alone Aren't Enough for Sustainable Weight Loss – STAAR LABS The GLP-1 Agonists and Obesity:

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

There 9 types of antidiabetic drugs, of which GLP-1RAs are the most popular, find the evolution of GLP-1RAs and their challenges and solutions,

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) have proven efficacy and safety in randomized clinical trials and observational real-life studies

Together, this combination does not provide clinical benefit due to similar mechanisms of action (see picture below)

However, most (59%) of same those employers say their cost for the drugs has exceeded expectations

Targets fat not muscle*: Morosil has been shown to reduce waist and hip circumference and support healthy body composition when paired with a balanced diet and exercise.